Tom ntej: Inclisiran Sodium CAS 1639324-58-5

Tom ntej: Inclisiran Sodium CAS 1639324-58-5

Paub meej
Inclisiran sodium CAS 1639324-58-5, yog thawj-hauv-chav siRNA tsim los ntawm Alnylam Pharmaceuticals Inc. Nws yog PCSK9 inhibitor. Tam sim no, theem siab tshaj plaws ntawm cov tshuaj no yog kev pom zoo rau kev lag luam, uas yog siv los kho hypercholesterolemia, dyslipidemia, kab mob carotid artery, heterozygous familial hypercholesterolemia thiab atherosclerosis.
Thaum Lub Kaum Ob Hlis 9, 2020, Inxlan sodium tau pom zoo los ntawm European Medicines Agency (EMA) thiab tau ua lag luam los ntawm Novartis Europharm Ltd raws li lub npe lag luam Leqvio®. (EMEA/H/C/005333).
Kev faib tawm yam khoom
Oligonucleotide
Share to
Xa kev nug
Hauj lwm lawm
Kev tsis

Zhejiang Hengkang Pharmaceutical Co., Ltd. yog ib qho ntawm feem txhim khu kev qha manufacturers thiab lwm tus neeg ntawm inclisiran sodium cas 1639324-58-5 nyob rau hauv Suav teb, featured los ntawm cov khoom zoo thiab cov kev pab zoo. Thov so assured mus ua lag luam wholesale bulk inclisiran sodium cas 1639324-58-5 ua nyob rau hauv Suav teb nov los ntawm peb lub hoobkas.

 

Khoom Taw Qhia

 

  • Inclisiran sodium API

Inclisiran sodium CAS 1639324-58-5

product-1286-302

Tshuaj npe

Inclisiran sodium

Cov qauv zoo

Hauv -HUS

Cov xwm txheej tam sim no

Qauv Muaj

 

Cim npe nrov: inclisiran sodium CAS 1639324-58-5, Tuam Tshoj inclisiran sodium CAS 1639324-58-5 manufacturers, lwm tus neeg, Hoobkas

Xa kev nug
CDMOKev Pabcuam

Dedicated rau tshiab tshuaj R & D thiab zus tau tej cov APIs thiab intermediates.

Hu rau tam sim no!